IRIS Accounts Production v22.1.4.3 09364536 director 1.4.21 31.3.22 31.3.22 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure093645362021-03-31093645362022-03-31093645362021-04-012022-03-31093645362020-03-31093645362020-04-012021-03-31093645362021-03-3109364536ns16:EnglandWales2021-04-012022-03-3109364536ns15:PoundSterling2021-04-012022-03-3109364536ns11:Director12021-04-012022-03-3109364536ns11:PrivateLimitedCompanyLtd2021-04-012022-03-3109364536ns11:SmallEntities2021-04-012022-03-3109364536ns11:AuditExempt-NoAccountantsReport2021-04-012022-03-3109364536ns11:SmallCompaniesRegimeForDirectorsReport2021-04-012022-03-3109364536ns11:SmallCompaniesRegimeForAccounts2021-04-012022-03-3109364536ns11:FullAccounts2021-04-012022-03-3109364536ns11:OrdinaryShareClass12021-04-012022-03-3109364536ns11:CompanySecretary12021-04-012022-03-3109364536ns11:RegisteredOffice2021-04-012022-03-3109364536ns6:CurrentFinancialInstruments2022-03-3109364536ns6:CurrentFinancialInstruments2021-03-3109364536ns6:Non-currentFinancialInstruments2022-03-3109364536ns6:Non-currentFinancialInstruments2021-03-3109364536ns6:ShareCapital2022-03-3109364536ns6:ShareCapital2021-03-3109364536ns6:RetainedEarningsAccumulatedLosses2022-03-3109364536ns6:RetainedEarningsAccumulatedLosses2021-03-3109364536ns6:MotorVehicles2021-03-3109364536ns6:ComputerEquipment2021-03-3109364536ns6:MotorVehicles2021-04-012022-03-3109364536ns6:ComputerEquipment2021-04-012022-03-3109364536ns6:MotorVehicles2022-03-3109364536ns6:ComputerEquipment2022-03-3109364536ns6:MotorVehicles2021-03-3109364536ns6:ComputerEquipment2021-03-3109364536ns6:CostValuation2021-03-3109364536ns6:AdditionsToInvestments2022-03-3109364536ns6:CostValuation2022-03-3109364536ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3109364536ns6:WithinOneYearns6:CurrentFinancialInstruments2021-03-3109364536ns6:DeferredTaxation2021-03-3109364536ns6:DeferredTaxation2021-04-012022-03-3109364536ns6:DeferredTaxation2022-03-3109364536ns11:OrdinaryShareClass12022-03-31
REGISTERED NUMBER: 09364536 (England and Wales)
















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2022

FOR

D MEDICAL LIMITED

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


D MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2022







DIRECTOR: Mr D Smith





SECRETARY: Mr D Smith





REGISTERED OFFICE: Fifth Floor
11 Leadenhall Street
London
EC3V 1L





REGISTERED NUMBER: 09364536 (England and Wales)





ACCOUNTANTS: Acuity Professional Partnership LLP
Chartered Accountants & Tax Advisers
Fifth Floor
11 Leadenhall Street
London
EC3V 1LP

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

STATEMENT OF FINANCIAL POSITION
31 MARCH 2022

2022 2021
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 99,897 5,810
Investments 5 20,000 5,000
119,897 10,810

CURRENT ASSETS
Debtors 6 622,054 212,285
Cash at bank and in hand 2,154,714 228,748
2,776,768 441,033
CREDITORS
Amounts falling due within one year 7 647,240 202,966
NET CURRENT ASSETS 2,129,528 238,067
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,249,425

248,877

CREDITORS
Amounts falling due after more than one year 8 (37,271 ) -

PROVISIONS FOR LIABILITIES 9 (18,980 ) (1,104 )
NET ASSETS 2,193,174 247,773

CAPITAL AND RESERVES
Called up share capital 10 1 1
Retained earnings 2,193,173 247,772
SHAREHOLDERS' FUNDS 2,193,174 247,773

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

STATEMENT OF FINANCIAL POSITION - continued
31 MARCH 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the director and authorised for issue on 13 August 2022 and were signed by:





Mr D Smith - Director


D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022


1. STATUTORY INFORMATION

D Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The preparation of financial statements in conformity with FRS 102 section 1A requires the use of certain critical accounting estimates. lt also requires management to exercise judgement in applying the company's accounting policies.

SIGNIFICANT JUDGEMENTS AND ESTIMATES
In preparing the financial statements, management were not required to make any estimates or judgements which materially affect reported income, expenses, assets, liabilities or disclosure of contingent assets and liabilities.

TURNOVER
Turnover comprises the value of consideration receivable from the customer for the rendering of services, net of value-added tax (VAT) rebates and discounts.

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2022


2. ACCOUNTING POLICIES - continued

FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognized in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognized amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortized cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortized.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors and bank loans that are classified as debt, are initially recognized at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payment discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortized.

Debt instruments are subsequently carried at amortized cost, using the effective interest rate method.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2022


2. ACCOUNTING POLICIES - continued

RESEARCH AND DEVELOPMENT
Research and development expenditure is written off in the profit and loss account in the year to which the expenditure relates. The tax relief on research and development expenditure will be recognised in the financial statements in the year it has been approved by HMRC.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer and office equipment 25% on reducing balance
Motor vehicles 25% on reducing balance

The assets residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2021 - 3 ) .

4. TANGIBLE FIXED ASSETS
Motor Computer
vehicles equipment Totals
£    £    £   
Cost
At 1 April 2021 - 15,403 15,403
Additions 107,148 2,723 109,871
At 31 March 2022 107,148 18,126 125,274
Depreciation
At 1 April 2021 - 9,593 9,593
Charge for year 14,017 1,767 15,784
At 31 March 2022 14,017 11,360 25,377
Net book value
At 31 March 2022 93,131 6,766 99,897
At 31 March 2021 - 5,810 5,810

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2022


5. FIXED ASSET INVESTMENTS
Other
investments
£   
Cost
At 1 April 2021 5,000
Additions 15,000
At 31 March 2022 20,000
Net book value
At 31 March 2022 20,000
At 31 March 2021 5,000

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade debtors 177,340 184,661
Other debtors - 4,000
Loan account 20,000 20,000
Directors' current accounts 322,944 -
VAT 101,770 -
Prepayments - 3,624
622,054 212,285

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Bank loans and overdrafts 9,586 -
Trade creditors 161,077 -
Taxation and social security 465,181 49,724
Other creditors 11,396 153,242
647,240 202,966

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2022 2021
£    £   
Bank loans 37,271 -

9. PROVISIONS FOR LIABILITIES
2022 2021
£    £   
Deferred tax 18,980 1,104

D MEDICAL LIMITED (REGISTERED NUMBER: 09364536)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2022


9. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 April 2021 1,104
Provided during year 17,876
Balance at 31 March 2022 18,980

10. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 2022 2021
value: £    £   
1 Ordinary £1 1 1